Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Quantitative plasma proteomics of survivor and non-survivor COVID-19 patients admitted to hospital unravels potential prognostic biomarkers and therapeutic targets

View ORCID ProfileDaniele C. Flora, View ORCID ProfileAline D. Valle, Heloisa A. B. S. Pereira, View ORCID ProfileThais F. Garbieri, View ORCID ProfileNathalia R. Buzalaf, Fernanda N. Reis, Larissa T. Grizzo, View ORCID ProfileThiago J. Dionisio, View ORCID ProfileAline L. Leite, View ORCID ProfileVirginia B. R. Pereira, Deborah M. C. Rosa, Carlos F. Santos, View ORCID ProfileMarília A. Rabelo Buzalaf
doi: https://doi.org/10.1101/2020.12.26.20248855
Daniele C. Flora
1Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil
4Bauru State Hospital, Bauru, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Daniele C. Flora
Aline D. Valle
1Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aline D. Valle
Heloisa A. B. S. Pereira
1Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thais F. Garbieri
1Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thais F. Garbieri
Nathalia R. Buzalaf
1Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Nathalia R. Buzalaf
Fernanda N. Reis
1Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Larissa T. Grizzo
1Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thiago J. Dionisio
1Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thiago J. Dionisio
Aline L. Leite
2Nebraska Center for Integrated Biomolecular Communication, University of Nebraska-Lincoln, Lincoln, NE, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Aline L. Leite
Virginia B. R. Pereira
3Adolfo Lutz Institute, Center of Regional Laboratories II - Bauru, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Virginia B. R. Pereira
Deborah M. C. Rosa
4Bauru State Hospital, Bauru, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos F. Santos
1Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marília A. Rabelo Buzalaf
1Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marília A. Rabelo Buzalaf
  • For correspondence: mbuzalaf@fob.usp.br
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The development of new approaches that allow early assessment of which cases of COVID-19 will likely become critical and the discovery of new therapeutic targets are urgent demands. In this cohort study, we performed proteomic and laboratorial profiling of plasma from 163 patients admitted to Bauru State Hospital (Bauru, SP, Brazil) between May 4th and July 4th, 2020, who were diagnosed with COVID-19 by RT-PCR nasopharyngeal swab samples. Plasma samples were collected upon admission for routine laboratory analyses and shotgun quantitative label-free proteomics. Based on the course of the disease, the patients were further divided into 3 groups: a) mild symptoms, discharged without admission to an intensive care unit (ICU) (n=76); b) severe symptoms, discharged after admission to an ICU (n=56); c) critical, died after admission to an ICU (n=31). White cells and neutrophils were significantly higher in severe and critical patients compared to mild ones. Lymphocytes were significantly lower in critical patients compared to mild ones and platelets were significantly lower in critical patients compared to mild and severe ones. Ferritin, TGO, urea and creatinine were significantly higher in critical patients compared to mild and severe ones. Albumin, CPK, LDH and D-dimer were significantly higher in severe and critical patients compared to mild ones. PCR was significantly higher in severe patients compared to mild ones. Proteomic analysis revealed marked changes between the groups in plasma proteins related to complement activation, blood coagulation, antimicrobial humoral response, acute inflammatory response, and endopeptidase inhibitor activity. Higher levels of IREB2, GELS, POLR3D, PON1 and ULBP6 upon admission to hospital were found in patients with mild symptoms, while higher levels of Gal-10 were found in critical and severe patients. This needs to be validated in further studies. If confirmed, pathways involving these proteins might be potential new therapeutic targets for COVID-19.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

We would like to thank State of Sao Paulo Research Foundation (FAPESP) for the financial support through the Thematic (#2015/03965/2) and Regular (#2018/12041/7) Projects, the National Council for Scientific and Technological Development (CNPq, #302371/2018/4 and #307986/2017-9) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) Finance Code 001.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This project was approved by the Ethical Committee of Bauru School of Dentistry, University of Sao Paulo (CAAE 31019820.8.0000.5417) upon acquiescence of the Nucleus of Teaching and Research of the Bauru State Hospital. Patients participated after they (or their relatives) signed an informed consent document.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵& Joint first authors

Data Availability

Upon request, the corresponding author may supplu the data. Additional analyses are still being conducted. After they are finished, all data will be deposited at the repository of the University of Sao Paulo.

http://dadoscientificos.usp.br

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted January 02, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Quantitative plasma proteomics of survivor and non-survivor COVID-19 patients admitted to hospital unravels potential prognostic biomarkers and therapeutic targets
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Quantitative plasma proteomics of survivor and non-survivor COVID-19 patients admitted to hospital unravels potential prognostic biomarkers and therapeutic targets
Daniele C. Flora, Aline D. Valle, Heloisa A. B. S. Pereira, Thais F. Garbieri, Nathalia R. Buzalaf, Fernanda N. Reis, Larissa T. Grizzo, Thiago J. Dionisio, Aline L. Leite, Virginia B. R. Pereira, Deborah M. C. Rosa, Carlos F. Santos, Marília A. Rabelo Buzalaf
medRxiv 2020.12.26.20248855; doi: https://doi.org/10.1101/2020.12.26.20248855
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Quantitative plasma proteomics of survivor and non-survivor COVID-19 patients admitted to hospital unravels potential prognostic biomarkers and therapeutic targets
Daniele C. Flora, Aline D. Valle, Heloisa A. B. S. Pereira, Thais F. Garbieri, Nathalia R. Buzalaf, Fernanda N. Reis, Larissa T. Grizzo, Thiago J. Dionisio, Aline L. Leite, Virginia B. R. Pereira, Deborah M. C. Rosa, Carlos F. Santos, Marília A. Rabelo Buzalaf
medRxiv 2020.12.26.20248855; doi: https://doi.org/10.1101/2020.12.26.20248855

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (76)
  • Allergy and Immunology (196)
  • Anesthesia (54)
  • Cardiovascular Medicine (489)
  • Dentistry and Oral Medicine (89)
  • Dermatology (56)
  • Emergency Medicine (168)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (211)
  • Epidemiology (5677)
  • Forensic Medicine (3)
  • Gastroenterology (215)
  • Genetic and Genomic Medicine (863)
  • Geriatric Medicine (88)
  • Health Economics (230)
  • Health Informatics (761)
  • Health Policy (390)
  • Health Systems and Quality Improvement (251)
  • Hematology (105)
  • HIV/AIDS (182)
  • Infectious Diseases (except HIV/AIDS) (6471)
  • Intensive Care and Critical Care Medicine (390)
  • Medical Education (117)
  • Medical Ethics (28)
  • Nephrology (91)
  • Neurology (847)
  • Nursing (44)
  • Nutrition (141)
  • Obstetrics and Gynecology (162)
  • Occupational and Environmental Health (258)
  • Oncology (514)
  • Ophthalmology (163)
  • Orthopedics (44)
  • Otolaryngology (105)
  • Pain Medicine (48)
  • Palliative Medicine (21)
  • Pathology (149)
  • Pediatrics (250)
  • Pharmacology and Therapeutics (146)
  • Primary Care Research (114)
  • Psychiatry and Clinical Psychology (965)
  • Public and Global Health (2226)
  • Radiology and Imaging (377)
  • Rehabilitation Medicine and Physical Therapy (174)
  • Respiratory Medicine (312)
  • Rheumatology (109)
  • Sexual and Reproductive Health (80)
  • Sports Medicine (82)
  • Surgery (118)
  • Toxicology (25)
  • Transplantation (34)
  • Urology (42)